PALMITOYLISOPROPYLAMIDE

Uses

An inhibitor of fatty acid amide hydrolase (FAAH). pIC50=4.89 for inhibition of [3H]-anandamide metabolism. Displays little binding to CB1 and CB2 receptors (IC50>100uM) and very weakly blocks ananadamide uptake (IC50~100uM). Inhibits proliferation of C6 glioma cells.

Uses

An inhibitor of fatty acid amide hydrolase (FAAH). pIC50=4.89 for inhibition of [3H]-anandamide metabolism. Displays little binding to CB1 and CB2 receptors (IC50>100uM) and very weakly blocks ananad amide uptake (IC50~100uM). Inhibits proliferation of C6 glioma cells.

Biological Activity

Inhibitor of fatty acid amide hydrolase (FAAH); pIC 50 = 4.89 for inhibition of [ 3 H]-anandamide metabolism. Displays little binding to CB 1 and CB 2 receptors (IC 50 > 100 μ M) and very weakly blocks anandamide uptake (IC 50 ~ 100 μ M). Inhibits proliferation of C6 glioma cells.